These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26050711)

  • 21. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
    O'Meara E; Clayton T; McEntegart MB; McMurray JJ; Lang CC; Roger SD; Young JB; Solomon SD; Granger CB; Ostergren J; Olofsson B; Michelson EL; Pocock S; Yusuf S; Swedberg K; Pfeffer MA;
    Circulation; 2006 Feb; 113(7):986-94. PubMed ID: 16476847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble TNFα receptor type I and hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients.
    Martínez-Ruiz A; Tornel-Osorio PL; Sánchez-Más J; Pérez-Fornieles J; Vílchez JA; Martínez-Hernández P; Pascual-Figal DA
    Clin Biochem; 2012 Nov; 45(16-17):1455-8. PubMed ID: 22609894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.
    Tang WH; Tong W; Jain A; Francis GS; Harris CM; Young JB
    J Am Coll Cardiol; 2008 Feb; 51(5):569-76. PubMed ID: 18237687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factors.
    Kunin M; Arad M; Dinour D; Freimark D; Holtzman EJ
    Blood Purif; 2013; 35(4):285-94. PubMed ID: 23712042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
    de Groote P; Delour P; Mouquet F; Lamblin N; Dagorn J; Hennebert O; Le Tourneau T; Foucher-Hossein C; Verkindère C; Bauters C
    Am Heart J; 2007 Sep; 154(3):589-95. PubMed ID: 17719311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
    Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJ; Yusuf S; Granger CB; Michelson EL; Ostergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ;
    Circulation; 2006 Feb; 113(5):671-8. PubMed ID: 16461840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Am Coll Cardiol; 2005 Mar; 45(5):661-7. PubMed ID: 15734608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of prognostic factors between young and elderly patients with chronic heart failure.
    Sato T; Yamauchi H; Kanno Y; Suzuki S; Yoshihisa A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    Geriatr Gerontol Int; 2015 Apr; 15(4):435-42. PubMed ID: 24730674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide. Guided vs. conventional care in outpatients with chronic heart failure: a retrospective study.
    De Vecchis R; Esposito C; Di Biase G; Ariano C
    Minerva Cardioangiol; 2013 Aug; 61(4):437-49. PubMed ID: 23846010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of formulas estimating excretory renal function in the elderly with systolic heart failure.
    Scrutinio D; Passantino A; Santoro D; Cacciapaglia E; Farinola G
    Age Ageing; 2009 May; 38(3):296-301. PubMed ID: 19252204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiorenal anemia syndrome as a prognosticator for death in heart failure.
    Lu KJ; Kearney LG; Hare DL; Ord M; Toia D; Jones E; Burrell LM; Srivastava PM
    Am J Cardiol; 2013 Apr; 111(8):1187-91. PubMed ID: 23375730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.